By TSUBASA SETOGUCHI/ Staff Writer
February 1, 2021 at 17:07 JST
An employee of Murase Glass Co. visually inspects glass vials in Asahi, Chiba Prefecture, on Jan. 29. (Tsubasa Setoguchi)
A Tokyo-based manufacturer is ramping up production of glass vials needed worldwide for COVID-19 vaccination programs.
Murase Glass Co., a company that processes needles and vials that are made of borosilicate glass in Tokyo’s Sumida Ward, has been flooded with orders from drug companies around the world since March 2020, when the novel coronavirus pandemic started raging.
The company, which was established in 1933, anticipates that demand will further grow and is preparing to boost production.
“I hope we are of some help in containing the national crisis as soon as possible for health care workers and industries that have been largely impacted by the pandemic,” said company President Koichi Murase, 50.
EDITORIAL: Collaboration with local entities vital for vaccine rollout program
January 30, 2021
AstraZeneca to make 90 million COVID-19 doses in Japan
January 28, 2021
VOX POPULI: Longing for the day to dine out in company again, instead of alone
January 30, 2021
VOX POPULI: Poets capture abnormality of daily life during the pandemic
September 25, 2020
Takeda-led COVID-19 plasma treatment unlikely to meet July goal of trial start
July 29, 2020
Goodbye mask, hello umbrella? Japan’s new trend for social distancing
July 29, 2020
Stories about memories of cherry blossoms solicited from readers
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series on the death of a Japanese woman that sparked a debate about criminal justice policy in the United States
A series about Japanese-Americans and their memories of World War II
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
